These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 34541561)

  • 1. The role of exercise in rehabilitation of discharged COVID-19 patients.
    Bo W; Xi Y; Tian Z
    Sports Med Health Sci; 2021 Dec; 3(4):194-201. PubMed ID: 34541561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
    Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
    Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy.
    Eskandarian Boroujeni M; Sekrecka A; Antonczyk A; Hassani S; Sekrecki M; Nowicka H; Lopacinska N; Olya A; Kluzek K; Wesoly J; Bluyssen HAR
    Front Immunol; 2022; 13():888897. PubMed ID: 35663932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.
    Liang Y; Wang ML; Chien CS; Yarmishyn AA; Yang YP; Lai WY; Luo YH; Lin YT; Chen YJ; Chang PC; Chiou SH
    Front Immunol; 2020; 11():1022. PubMed ID: 32574260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into forsythia honeysuckle (Lianhuaqingwen) capsules: A Chinese herbal medicine repurposed for COVID-19 pandemic.
    Liang C; Hui N; Liu Y; Qiao G; Li J; Tian L; Ju X; Jia M; Liu H; Cao W; Yu P; Li H; Ren X
    Phytomed Plus; 2021 May; 1(2):100027. PubMed ID: 35399819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Severe COVID-19 with Tocilizumab Mitigates Cytokine Storm and Averts Mechanical Ventilation During Acute Respiratory Distress: A Case Report and Literature Review.
    Farooqi F; Dhawan N; Morgan R; Dinh J; Nedd K; Yatzkan G
    Trop Med Infect Dis; 2020 Jul; 5(3):. PubMed ID: 32635353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case Report: Canakinumab for the Treatment of a Patient With COVID-19 Acute Respiratory Distress Syndrome.
    Caracciolo M; Macheda S; Labate D; Tescione M; La Scala S; Vadalà E; Squillaci R; D'Aleo F; Morabito A; Garreffa C; Marciano MC; Oliva EN
    Front Immunol; 2020; 11():1942. PubMed ID: 32983123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Acute Respiratory Syndrome Coronavirus-2 Induces Cytokine Storm and Inflammation During Coronavirus Disease 19: Perspectives and Possible Therapeutic Approaches.
    Mannino F; Bitto A; Irrera N
    Front Pharmacol; 2020; 11():592169. PubMed ID: 33633566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified rehabilitation exercises for mild cases of COVID-19.
    Zha L; Xu X; Wang D; Qiao G; Zhuang W; Huang S
    Ann Palliat Med; 2020 Sep; 9(5):3100-3106. PubMed ID: 32787373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.
    Guo YR; Cao QD; Hong ZS; Tan YY; Chen SD; Jin HJ; Tan KS; Wang DY; Yan Y
    Mil Med Res; 2020 Mar; 7(1):11. PubMed ID: 32169119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary Fibrosis Caused by Severe COVID-19 Infection: Discharge May Not Be The End of Treatment.
    Rumende CM
    Acta Med Indones; 2021 Apr; 53(2):141-142. PubMed ID: 34251340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine storm induced by SARS-CoV-2.
    Song P; Li W; Xie J; Hou Y; You C
    Clin Chim Acta; 2020 Oct; 509():280-287. PubMed ID: 32531256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of socioeconomic status on functional recovery after ARDS caused by SARS-CoV-2: a multicentre, observational study.
    Declercq PL; Fournel I; Demeyere M; Ksiazek E; Meunier-Beillard N; Rivière A; Clarot C; Maizel J; Schnell D; Plantefeve G; Ampere A; Daubin C; Sauneuf B; Kalfon P; Federici L; Redureau É; Bousta M; Lagache L; Vanderlinden T; Nseir S; La Combe B; Bourdin G; Monchi M; Nyunga M; Ramakers M; Oulehri W; Georges H; Salmon Gandonniere C; Badie J; Delbove A; Monnet X; Beduneau G; Artaud-Macari É; Abraham P; Delberghe N; Le Bouar G; Miailhe AF; Hraiech S; Bironneau V; Sedillot N; Hoppe MA; Barbar SD; Calcaianu GD; Dellamonica J; Terzi N; Delpierre C; Gélinotte S; Rigaud JP; Labruyère M; Georges M; Binquet C; Quenot JP;
    BMJ Open; 2022 Apr; 12(4):e057368. PubMed ID: 35459672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Review of Changes and Recovery in Physical Function and Fitness After Severe Acute Respiratory Syndrome-Related Coronavirus Infection: Implications for COVID-19 Rehabilitation.
    Rooney S; Webster A; Paul L
    Phys Ther; 2020 Sep; 100(10):1717-1729. PubMed ID: 32737507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) - anatomic pathology perspective on current knowledge.
    Mohanty SK; Satapathy A; Naidu MM; Mukhopadhyay S; Sharma S; Barton LM; Stroberg E; Duval EJ; Pradhan D; Tzankov A; Parwani AV
    Diagn Pathol; 2020 Aug; 15(1):103. PubMed ID: 32799894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging Mechanisms of Pulmonary Vasoconstriction in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS) and Potential Therapeutic Targets.
    Karmouty-Quintana H; Thandavarayan RA; Keller SP; Sahay S; Pandit LM; Akkanti B
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33138181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of aerosolized intra-tracheal dornase alfa administration in patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS): a structured summary of a study protocol for a randomised controlled trial.
    Desilles JP; Gregoire C; Le Cossec C; Lambert J; Mophawe O; Losser MR; Lambiotte F; Le Tacon S; Cantier M; Engrand N; Trouiller P; Pottecher J
    Trials; 2020 Jun; 21(1):548. PubMed ID: 32560746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 infection: an overview on cytokine storm and related interventions.
    Montazersaheb S; Hosseiniyan Khatibi SM; Hejazi MS; Tarhriz V; Farjami A; Ghasemian Sorbeni F; Farahzadi R; Ghasemnejad T
    Virol J; 2022 May; 19(1):92. PubMed ID: 35619180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
    Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K
    J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.